Get the Stockscreener App
316.44
1.73%
5.37
Pre-market:
321.77
5.33
+1.68%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $316.44, with a volume of 2.72M.
It is up +1.73% in the last 24 hours and up +2.76% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$311.07
Open:
$313
24h Volume:
2.72M
Relative Volume:
1.02
Market Cap:
$121.31B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
36.65
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
-3.18%
1M Performance:
+2.76%
6M Performance:
-12.70%
1Y Performance:
-18.98%
1-Day Range:
$310.36
$317.49
1-Week Range:
$306.53
$336.15
52-Week Range:
$281.00
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
316.44 | 127.06B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
89.27 | 160.44B | 45.13B | 6.28B | 7.38B | 3.5895 |
MDT
Medtronic Plc
|
80.47 | 106.97B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
43.04 | 66.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.27 | 52.85B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corp. stock underperforms Tuesday when compared to competitors - MSN
Stryker Corp (SYK) Stock Down 6.2% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating - Moomoo
Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis - TradingKey
Fund Update: 43,404 STRYKER (SYK) shares added to Douglas Lane & Associates, LLC portfolio - Quiver Quantitative
Stryker Slides As Investors Reassess Cyberattack Recovery Ahead Of Q2 Results - Quiver Quantitative
BTIG Research Adjusts Stryker Price Target to $371 From $379, Maintains Buy Rating - Moomoo
Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Piper Sandler reiterates Stryker stock rating on Mako strength - Investing.com
Piper Sandler reiterates Stryker stock rating on Mako strength By Investing.com - Investing.com Canada
Stryker Corp Stock Operating Data - GuruFocus
Stryker Corp (FRA:SYK0) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Stryker (FRA:SYK0) Interest Paid - GuruFocus
Stryker Corp (FRA:SYK0) Competitors 2026 - GuruFocus
Stryker Corp (FRA:SYK0) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Stryker Corp (FRA:SYK0) Stock Price & 30 Year Financial Data - GuruFocus
Stryker Corp (FRA:SYK0) Valuation: Modestly Undervalued - GuruFocus
FRA:SYK0 Dividend: Does Stryker Corp Pay a Dividend? - GuruFocus
Stryker Corp (FRA:SYK0) Stock Earnings Transcripts - GuruFocus
Stryker Corp Stock Warning Signs - GuruFocus
Who's Buying or Selling Stryker Corp (FRA:SYK0) Stock Today? - GuruFocus
Stryker Corp (FRA:SYK0) Stock News, Headlines & Updates - GuruFocus
Argus raises Stryker stock price target on cyberattack recovery By Investing.com - Investing.com Australia
Argus raises Stryker stock price target on cyberattack recovery - Investing.com
Inside medtech’s cameo run on HBO Max’s ‘The Pitt’ - Modern Healthcare
Argus Research Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $370 - Moomoo
Stryker's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance - Insider Monkey
SYK Initiates Coverage On Stryker -- Price Target Announced at $369 - GuruFocus
Argus Research Adjusts Stryker Price Target to $370 From $350 - Moomoo
Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic - Yahoo Finance
Stryker Corp. focuses on innovation as medical device demand grows - AD HOC NEWS
Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $385 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Stryker Corp. highlights its medical technology reach as a major S&P 500 healthcare name - ad-hoc-news.de
Stryker Neptune 3 Waste Management System from Stryker Corp.quiet workhorse in US operating rooms - ad-hoc-news.de
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stericycle stock reflects a steady business profile. SRCL stays tied to regulated medical waste - AD HOC NEWS
Stryker Corp highlights its medical technology reach as investors track the stock - Ad-hoc-news.de
Evercore Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $350 - Moomoo
Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income - ChartMill
The Mako SmartRobotics system from Stryker Corp.precision knee and hip surgeries across US hospit - AD HOC NEWS
Is Stryker Corp. (SYK) The Best Robotic Stock to Buy? - Yahoo Finance
Railway Pension Investments Ltd's Stryker Corp(SYK) Holding History - GuruFocus
SYK News | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker Corp (SYK) Shares Surge 4.2% -- What GF Score of 92 Tells Investors - GuruFocus
Stryker Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Workers Withdraw Claims in Stryker Wiper Attack Lawsuit - BankInfoSecurity
Stryker cyberattack lawsuits dismissed - WZZM13.com
Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation - Yahoo Finance
Stryker Corp. focuses on medical technology growth as investors track its U.S. hospital exposure - AD HOC NEWS
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Stryker Corp Stock (SYK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
1.48%
3.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):